Acarbose in the treatment of elderly patients with type 2 diabetes
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Aims To study the effect of acarbose, an alpha-glucosidase inhibitor, on glycemic control in elderly patients with type 2 diabetes.Methods Elderly patients with type 2 diabetes treated with diet alone were randomly treated in a double-blind fashion with placebo (n=99) or acarbose (n=93) for 12 months.Results After 12 months of therapy, there was a statistically significant difference in the change in glycated haemoglobin (HbA(1c)) (-0.6%) in the acarbose group versus placebo, as well as in the incremental post-prandial glucose values (-2.1 mmol h/l) and mean fasting plasma glucose (-0.7 mmol/l). Although there was no effect of acarbose on insulin release, there was a clear effect of acarbose to decrease relative insulin resistance (-0.8) (HOMA method). In addition, acarbose was generally well tolerated and safe in the elderly; most discontinuations were due to gastrointestinal side effects such as flatulence and diarrhea. There were no cases of hypoglycemia reported, and no clinically relevant changes in laboratory abnormalities or vital signs during the study.Conclusions Acarbose improves the glycemic profile and insulin sensitivity in elderly patients with type 2 diabetes who are inadequately controlled on diet alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A-glucosidase inhibitors, such as acarbose, miglitol and voglibose, not only decelerate the breakdown of starch into glucose in the small intestine but also decrease its bioavailability, resulting in reduced levels of glucose entering the blood stream and hence attenuated postprandial glucose excursions.365, 366, 367, 368, 369, 370”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [367]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 2×
“Insulin sensitivity was calculated from fasting plasma insulin and glucose values by the HOMA method, as previously described [7].”
MethodSF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Rossetti, L., Giaccari, A., & DeFronzo, R. A. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.610 · Cited by 770
NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects
Kuusisto, J., Mykkänen, L., Pyörälä, K., & Laakso, M. (1994) · Diabetes · doi:10.2337/diab.43.8.960 · Cited by 591 · cited 1×
“Given that several epidemiologic studies have shown a strong relationship between HbA1c and the risk of macrovascular complications in elderly patients with diabetes, it is plausible that the modest reduction in HbA1c achieved in this study would have clinical benefit [15].”
Background1998 clinical practice guidelines for the management of diabetes in Canada
Meltzer, S. J., Leiter, L. A., Daneman, D., Gerstein, H. C., Lau, D. C. W., Ludwig, S. M., Yale, J., Zinman, B., Lillie, D., & Steering, C. (1998) · Canadian Medical Association Journal · Cited by 455
Self-citationChiasson, J.-L., Josse, R. G., Hunt, J. A., Palmason, C., Rodger, N. W., Ross, S. A., Ryan, E. A., Tan, M. H., & Wolever*, T. M. S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00004 · Cited by 436
Self-citationBonora, E., & Muggeo, M. (2001) · Diabetologia · doi:10.1007/s001250100020 · Cited by 420 · cited 1×
“In addition, increasing evidence suggests that, relative to fasting glucose and HbA1c, post-prandial hyperglycemia is a better predictor of cardiovascular morbidity and mortality in patients with diabetes [16].”
Background
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Hanefeld, M. (2004) · European Heart Journal · doi:10.1016/s0195-668x(03)00468-8 · Cited by 641
Type 2 diabetes mellitus in older adults: clinical considerations and management
Bellary, S., Kyrou, I., Brown, J. E., & Bailey, C. J. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00512-2 · Cited by 639
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 568
“trointestinal adverse effects of flatulence and diarrhea tend to cause a relatively high rate of nonadherence (141).”
BackgroundHypoglycaemia in Type 2 diabetes
Amiel, S. A., Dixon, T., Mann, R., & Jameson, K. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02341.x · Cited by 472
Metadata
- Authors
- Josse, R. G., Chiasson, J.-L., Ryan, E. A., Lau, D. C. W., Ross, S. A., Yale, J.-F., Leiter, L. A., Maheux, P., Tessier, D., Wolever, T. M. S., Gerstein, H., Rodger, N. W., Dornan, J. M., Murphy, L. J., Rabasa-Lhoret, R., & Meneilly, G. S.
- Affiliations
- University of Toronto (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- University of Alberta (CA)
- University of Calgary (CA)
- McGill University (CA)
- Université de Sherbrooke (CA)
- McMaster University (CA)
- Western University (CA)
- Saint John Regional Hospital (CA)
- University of Manitoba (CA)
- University of British Columbia Hospital (CA)
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 59
- Issue
- 1
- Pages
- 37-42
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2118451434
- Cited by
- 110
- References
- 20
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 5 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 6 · 2013: 3 · 2012: 2
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Diabetes Research and Clinical Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- acarbose, alpha-glucosidase inhibitors, type 2 diabetes, elderly patients, glycemic control, HbA1c, postprandial blood glucose, fasting blood glucose, insulin resistance, insulin secretion, gastrointestinal adverse effects, drug safety
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Double-Blind Method, Female, Flatulence, Humans, Hypoglycemic Agents, Male, Treatment Outcome, Acarbose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acarbose in the treatment of elderly patients with type 2 diabetes. https://app.cochat.ai/papers/10.1016/s0168-8227(02)00176-6
- The paper
- Josse, R. G., Chiasson, J.-L., Ryan, E. A., Lau, D. C. W., Ross, S. A., Yale, J.-F., Leiter, L. A., Maheux, P., Tessier, D., Wolever, T. M. S., Gerstein, H., Rodger, N. W., Dornan, J. M., Murphy, L. J., Rabasa-Lhoret, R., & Meneilly, G. S. (2003). Acarbose in the treatment of elderly patients with type 2 diabetes. Diabetes Research and Clinical Practice. https://doi.org/10.1016/s0168-8227(02)00176-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.